LearnGlossaryMarketStocksSuperinvestorsSign in

WVE

Wave Life Sciences Ltd.

Healthcare · $715M market cap

Verdict

We can't put a fair value on WVE right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-16.4% a year✗
Sales growth40.8% a year✓
Free cash flow growth—?
Return on invested capital-51.3%✗

Follow WVE

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds WVE. In Q1 2026, 1 added. Who we track

Lee Ainslie

Maverick Capital · as of Q2 2026

$59.7M

10,278,115 shares

Moves in Q1 2026

Added: Lee Ainslie

About Wave Life Sciences Ltd.

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company’s medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is…

Biotechnology

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works